Farhat Nesrine, Cools Bjorn, Gewillig Marc, Seghaye Marie-Christine, Aggoun Yacine, Beghetti Maurice
Department of Pediatrics, University Hospital Liège, Liège, Belgium.
Pediatric Cardiology Unit and Centre Universitaire Romand de Cardiologie et Chirurgie Cardiaque Pédiatrique, Lausanne University Hospital (CHUV), Geneva University Hospitals (HUG), University of Geneva, Geneva, Switzerland.
Front Pediatr. 2019 Jul 4;7:262. doi: 10.3389/fped.2019.00262. eCollection 2019.
A 5-year-old girl presented with acute nocturnal episodes of loss of consciousness following abdominal pain and crying. Epilepsy was primarily diagnosed but the course of the disease was suggestive of pulmonary hypertension. An adapted invasive assessment of pulmonary pressure and pharmacological challenge allowed for diagnosing vasoreactive pulmonary arterial hypertension. Initial treatment with sildenafil was not effective. Thus, calcium channel blockers were introduced when positive vasoreactivity was confirmed and permitted to stop the occurrence of the syncope and dramatically improved clinical status. At 2 years follow-up she is well without any complaint and in functional class I. Echocardiography shows a slightly enlarged but not hypertrophied right ventricle with a nearly normalized estimated right ventricular pressure. The last catheterization shows subnormal values of pulmonary arterial pressure (mean pulmonary artery pressure: 24 mmHg) and pulmonary vascular resistance (5, 4 Wood unitsm), normalizing with inhaled Nitric Oxide (mean pulmonary artery pressure of 14 mmHg and pulmonary vascular resistance of 1.5 Wood unitsm). Vasoreactive pulmonary arterial hypertension is a rare entity in children but it should not be misdiagnosed with seizures due to the presence of syncopal episodes. According to current knowledge, this form seems to have a better prognosis than non-reactive pulmonary arterial hypertension and the treatment of choice remains as calcium channel blockers. The management of this case was characterized by successive mishaps and potentially harmful mistakes and underscores the potential risk with pediatric PH evaluation in non-expert centers.
一名5岁女孩在腹痛哭闹后出现急性夜间意识丧失发作。最初诊断为癫痫,但疾病进程提示有肺动脉高压。经过调整的肺动脉压力侵入性评估和药物激发试验确诊为血管反应性肺动脉高压。初始使用西地那非治疗无效。因此,在确认阳性血管反应性后引入钙通道阻滞剂,这使得晕厥停止发作,临床状况显著改善。在2年的随访中,她情况良好,无任何不适,心功能分级为I级。超声心动图显示右心室轻度扩大但无肥厚,估计右心室压力接近正常。最近一次心导管检查显示肺动脉压(平均肺动脉压:24 mmHg)和肺血管阻力(5.4 Wood单位/m)低于正常水平,吸入一氧化氮后恢复正常(平均肺动脉压为14 mmHg,肺血管阻力为1.5 Wood单位/m)。血管反应性肺动脉高压在儿童中是一种罕见疾病,但由于存在晕厥发作,不应误诊为癫痫。根据目前的知识,这种类型似乎比无反应性肺动脉高压预后更好,治疗选择仍然是钙通道阻滞剂。该病例的管理特点是接连出现意外情况和潜在的有害失误,突出了非专业中心儿童肺动脉高压评估的潜在风险。